» Articles » PMID: 31308352

Is Fasting Beneficial for Hospitalized Patients with Inflammatory Bowel Diseases?

Overview
Journal Intest Res
Date 2019 Jul 17
PMID 31308352
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Patients with inflammatory bowel disease (IBD) are usually hospitalized because of aggravated gastrointestinal symptoms. Many clinicians empirically advise these patients to fast once they are admitted. However, there has been no evidence that maintaining a complete bowel rest improves the disease course. Therefore, we aimed to investigate the effects of fasting on disease course in admitted patients with IBD or intestinal Behçet's disease.

Methods: A total of 222 patients with IBD or intestinal Behçet's disease, who were admitted for disease-related symptoms, were retrospectively analyzed. We divided them into 2 groups: fasting group (allowed to take sips of water but no food at the time of admission) and dietary group (received liquid, soft, or general diet).

Results: On admission, 124 patients (55.9%) started fasting and 98 patients (44.1%) started diet immediately. Among patients hospitalized through the emergency room, a significantly higher proportion underwent fasting (63.7% vs. 21.4%, P<0.001); however, 96.0% of the patients experienced dietary changes. Corticosteroid use (P<0.001; hazard ratio, 2.445; 95% confidence interval, 1.506-3.969) was significantly associated with a reduction in the disease activity score, although there was no significant difference between the fasting group and the dietary group in disease activity reduction (P=0.111) on multivariate analysis.

Conclusions: In terms of disease activity reduction, there was no significant difference between the fasting and dietary groups in admitted patients with IBD, suggesting that imprudent fasting is not helpful in improving the disease course. Therefore, peroral diet should not be avoided unless not tolerated by the patient.

Citing Articles

Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective.

Qin L, Lv W Nutr J. 2025; 24(1):12.

PMID: 39849464 PMC: 11755847. DOI: 10.1186/s12937-025-01075-y.


Optimizing Nutrition to Enhance the Treatment of Patients With Inflammatory Bowel Disease.

Vasudevan J, DiVincenzo C, Feagins L Gastroenterol Hepatol (N Y). 2022; 18(2):95-103.

PMID: 35505813 PMC: 9053508.


Effect of Ramadan intermittent fasting on inflammatory markers, disease severity, depression, and quality of life in patients with inflammatory bowel diseases: A prospective cohort study.

Negm M, Bahaa A, Farrag A, Lithy R, Badary H, Essam M BMC Gastroenterol. 2022; 22(1):203.

PMID: 35462542 PMC: 9036734. DOI: 10.1186/s12876-022-02272-3.

References
1.
Forbes A, Escher J, Hebuterne X, Klek S, Krznaric Z, Schneider S . ESPEN guideline: Clinical nutrition in inflammatory bowel disease. Clin Nutr. 2017; 36(2):321-347. DOI: 10.1016/j.clnu.2016.12.027. View

2.
Triantafillidis J, Vagianos C, Papalois A . The role of enteral nutrition in patients with inflammatory bowel disease: current aspects. Biomed Res Int. 2015; 2015:197167. PMC: 4352452. DOI: 10.1155/2015/197167. View

3.
Klaassen J, Zapata R, Mella J, Aguayo G, Alvarado D, Espinosa O . [Enteral nutrition in severe ulcerative colitis. Digestive tolerance and nutritional efficiency]. Rev Med Chil. 1998; 126(8):899-904. View

4.
Shiloni E, Coronado E, Freund H . Role of total parenteral nutrition in the treatment of Crohn's disease. Am J Surg. 1989; 157(1):180-5. DOI: 10.1016/0002-9610(89)90443-1. View

5.
Wright R, TRUELOVE S . A CONTROLLED THERAPEUTIC TRIAL OF VARIOUS DIETS IN ULCERATIVE COLITIS. Br Med J. 1965; 2(5454):138-41. PMC: 1845668. DOI: 10.1136/bmj.2.5454.138. View